Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.

MLA

Banna, Giuseppe Luigi, et al. “Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.” Current Oncology Reports, vol. 24, no. 12, Dec. 2022, pp. 1851–62. EBSCOhost, https://doi.org/10.1007/s11912-022-01335-8.

APA

Banna, G. L., Friedlaender, A., Tagliamento, M., Mollica, V., Cortellini, A., Rebuzzi, S. E., Prelaj, A., Naqash, A. R., Auclin, E., Garetto, L., Mezquita, L., & Addeo, A. (2022). Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer. Current Oncology Reports, 24(12), 1851–1862. https://doi.org/10.1007/s11912-022-01335-8

Chicago

Banna, Giuseppe Luigi, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, et al. 2022. “Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.” Current Oncology Reports 24 (12): 1851–62. doi:10.1007/s11912-022-01335-8.